O'Shaughnessy Asset Management’s Bionano Genomics BNGO Stock Holding History

O'Shaughnessy Asset Management’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18	Closed	-$15K	–	1340
2022 Q2	$15K	Hold	18	–	–	﹤0.01%	1210
2022 Q1	$27K	Hold	18	–	–	﹤0.01%	1202
2021 Q4	$31K	Hold	18	–	–	﹤0.01%	1191
2021 Q3	$58K	Buy	+18	New	+$63K	﹤0.01%	1584

Other funds holding BNGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

O'Shaughnessy Asset Management's BNGO Position: Q3 2022 in Review

O'Shaughnessy Asset Management sold out of Bionano Genomics (BNGO) in Q3 2022, closing a stake of 18 shares — an estimated $15K sold.

O'Shaughnessy Asset Management first reported a position in BNGO in Q3 2021 and held it in 4 quarters. The position peaked at $58K in Q3 2021. 140 funds tracked by Wall St. Rank hold BNGO as of Q3 2022.

O'Shaughnessy Asset Management reported no remaining Bionano Genomics position as of Q3 2022 after selling out during the quarter.
O'Shaughnessy Asset Management sold 18 Bionano Genomics shares in Q3 2022, an estimated $15K.
O'Shaughnessy Asset Management first reported a position in Bionano Genomics in Q3 2021 and held it in 4 quarters.
O'Shaughnessy Asset Management's Bionano Genomics position peaked at $58K in Q3 2021.
140 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2022.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.